Suntou-gun, Japan

Kozue Muramatsu

This inventor holds 1 USPTO granted patent. Top assignee: Kyowa Hakko Kogyo Co., Ltd.. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kozue Muramatsu. Retrieved from https://idiyas.com/inventor/kozue-muramatsu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Kozue Muramatsu

Introduction

Kozue Muramatsu is a notable inventor based in Sunto-gun, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of steroid sulfatase inhibitors. Her work has the potential to impact various therapeutic areas.

Latest Patents

Kozue Muramatsu holds 1 patent for her invention titled "Estra-1,3,5(10)-triene derivatives." This patent provides a formulation of steroid sulfatase inhibitors that includes an estra-1,3,5(10)-triene derivative as the active ingredient. The detailed chemical structure and potential applications of this invention highlight its significance in medical research.

Career Highlights

Throughout her career, Kozue has demonstrated a strong commitment to innovation in the pharmaceutical industry. Her work at Kyowa Hakko Kogyo Co., Ltd. has positioned her as a key player in the development of new therapeutic agents. Her contributions are recognized within the scientific community for their potential to advance treatment options.

Collaborations

Kozue has collaborated with esteemed colleagues such as Yoji Ino and Nobuyoshi Amishiro. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Kozue Muramatsu's innovative work in the field of steroid sulfatase inhibitors exemplifies her dedication to advancing pharmaceutical science. Her contributions are paving the way for future developments in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…